Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection

Current hepatitis C virus (HCV) treatment guidelines recommend treating HCV/human immunodeficiency virus (HIV)-coinfected individuals similar to HCV-monoinfected individuals. Recently inferior response rates to direct acting antiviral (DAA) therapy in HCV/HIV coinfection have been reported. Our Germ...

Descripción completa

Detalles Bibliográficos
Autores principales: Boesecke, Christoph, Ingiliz, Patrick, Berger, Florian, Lutz, Thomas, Schewe, Knud, Schulze zur Wiesch, Julian, Baumgarten, Axel, Christensen, Stefan, Rockstroh, Jürgen K, Mauss, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604144/
https://www.ncbi.nlm.nih.gov/pubmed/28948181
http://dx.doi.org/10.1093/ofid/ofx158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604144/
https://www.ncbi.nlm.nih.gov/pubmed/28948181
http://dx.doi.org/10.1093/ofid/ofx158

Ejemplares similares